Sesquiterpene lactone suppresses vascular smooth muscle cell proliferation and migration via inhibition of cell cycle progression. 2007

Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu 501-1194, Japan.

Abnormal vascular smooth muscle cell (VSMC) proliferation and migration are involved in restenosis following percutaneous transluminal angioplasty (PTCA) as well as in the development and progression of atherosclerosis. We investigated the mechanisms underlying the inhibitory effect of the sesquiterpene 3-oxo-5alphaH,8betaH-eudesma-1,4(15),7(11)-trien-8,12-olide (1) on rat VSMC proliferation and migration. VSMCs were isolated from rat aorta, and then the effect of 1 on cell proliferation and migration was examined using methylthiazolyldiphenyl-tetrazolium bromide (MTT) and chemotaxis assays, respectively. Compound 1 had a potent inhibitory effect on fetal calf serum-induced VSMC proliferation. This effect correlated with reduced expression of cyclin D(1). In addition, 1 also inhibited platelet derived growth factor (PDGF)-induced migration of VSMCs. These results indicate that 1 is a promising candidate for additional biological evaluation to further define its potential as an inhibitory modulator of VSMC responses that contribute to restenosis following PTCA and to the development and progression of atherosclerosis.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
October 2005, Circulation research,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
November 2007, Journal of cardiovascular pharmacology,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
February 2009, Atherosclerosis,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
January 2015, Journal of receptor and signal transduction research,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
November 2012, The Journal of pharmacology and experimental therapeutics,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
July 1999, The Journal of surgical research,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
January 2021, Open life sciences,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
March 1993, Haemostasis,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
September 2019, Experimental and therapeutic medicine,
Munehiro Nakagawa, and Takamasa Ohno, and Rumi Maruyama, and Munenori Okubo, and Akito Nagatsu, and Makoto Inoue, and Hiroki Tanabe, and Genzou Takemura, and Shinya Minatoguchi, and Hisayoshi Fujiwara
February 2008, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!